Endo Pharm patents expiration

1. Supprelin La patents expiration

SUPPRELIN LA's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8062652 ENDO PHARM Compositions and methods for treating precocious puberty
Jun, 2026

(2 years from now)

Drugs and Companies using HISTRELIN ACETATE ingredient

Market Authorisation Date: 03 May, 2007

Treatment: Method of treatment of children with central precocious puberty


More Information on Dosage

SUPPRELIN LA family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic